Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$60.27 - $90.75 $7,774 - $11,706
-129 Reduced 2.67%
4,702 $388 Million
Q2 2023

Aug 08, 2023

SELL
$82.41 - $99.65 $4,614 - $5,580
-56 Reduced 1.15%
4,831 $405 Million
Q1 2023

May 15, 2023

SELL
$47.76 - $82.86 $67,198 - $116,584
-1,407 Reduced 22.35%
4,887 $403 Million
Q4 2022

May 15, 2023

BUY
$48.76 - $77.67 $306,895 - $488,854
6,294 New
6,294 $321 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Klr Investment Advisors, LLC Portfolio

Follow Klr Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klr Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klr Investment Advisors, LLC with notifications on news.